Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweegen is a global biotechnology company specializing in the development and production of nature-based, non-GMO sweeteners and taste modulation solutions. The company utilizes proprietary bioconversion and precision fermentation technologies to produce high-purity steviol glycosides, such as Rebaudiosides M, D, and E, which serve as high-intensity sugar replacements. Beyond sweeteners, Sweegen offers a portfolio of taste tools designed to mask bitterness, enhance mouthfeel, and manage the sensory profiles of health-conscious food and beverage products. By focusing on sugar reduction, the company addresses global health challenges such as obesity and diabetes through innovative ingredient science. Headquartered in California, Sweegen operates advanced manufacturing facilities and maintains a strategic distribution partnership with Ingredion to reach global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweegen.